Baveno VI Recommendation on Avoidance of Screening Endoscopy in Cirrhotic Patients: Not Quite There Yet!
作者信息
Rodrigues Susana
机构信息
Department of Gastroenterology, Centro Hospitalar de São João, Porto, Portugal.
出版信息
GE Port J Gastroenterol. 2017 Mar;24(2):58-60. doi: 10.1159/000456092. Epub 2017 Feb 9.
Abstract
摘要
相似文献
1
Baveno VI Recommendation on Avoidance of Screening Endoscopy in Cirrhotic Patients: Not Quite There Yet!巴韦诺VI关于避免对肝硬化患者进行筛查性内镜检查的建议：仍未完全实现！
GE Port J Gastroenterol. 2017 Mar;24(2):58-60. doi: 10.1159/000456092. Epub 2017 Feb 9.
2
Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.验证 Baveno VI 标准以识别低风险肝硬化患者，这些患者无需进行静脉曲张内镜监测。
J Hepatol. 2016 Nov;65(5):899-905. doi: 10.1016/j.jhep.2016.06.021. Epub 2016 Jul 5.
3
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.Baveno VI 标准在代偿期肝硬化和持续抗病毒治疗应答患者食管静脉曲张筛查和监测中的验证。
Gastroenterology. 2019 Mar;156(4):997-1009.e5. doi: 10.1053/j.gastro.2018.11.053. Epub 2019 Feb 13.
4
The noninvasive diagnosis of esophageal varices and its application in clinical practice.食管静脉曲张的无创诊断及其在临床实践中的应用
Clin Res Hepatol Gastroenterol. 2018 Feb;42(1):6-16. doi: 10.1016/j.clinre.2017.07.006. Epub 2017 Sep 1.
5
Non-invasive diagnosis of esophageal varices after Baveno VI.巴韦诺VI标准之后食管静脉曲张的无创诊断
Turk J Gastroenterol. 2017 May;28(3):159-165. doi: 10.5152/tjg.2017.16744.
6
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.非酒精性脂肪性肝病肝硬化通过硬度和血小板对食管静脉曲张的无创预测。
J Hepatol. 2018 Oct;69(4):878-885. doi: 10.1016/j.jhep.2018.05.019. Epub 2018 May 24.
7
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.基于脾脏硬度测量和 Baveno VI 标准的联合模型排除晚期慢性肝病高危静脉曲张。
J Hepatol. 2018 Aug;69(2):308-317. doi: 10.1016/j.jhep.2018.04.023. Epub 2018 May 3.
8
Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.在不符合 Baveno VI 标准的患者中，通过肝硬度和血清标志物来排除高危静脉曲张。
World J Gastroenterol. 2019 Sep 21;25(35):5323-5333. doi: 10.3748/wjg.v25.i35.5323.
9
Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.验证 Baveno VI 及扩展的 Baveno VI 标准，以确定可以避免筛查性内镜检查的患者。
Liver Int. 2018 Aug;38(8):1442-1448. doi: 10.1111/liv.13732. Epub 2018 Mar 25.
10
Large oesophageal varice screening by a sequential algorithm using a cirrhosis blood test and optionally capsule endoscopy.使用肝硬化血液检测和可选胶囊内镜的序贯算法进行大规模食管静脉曲张筛查。
Liver Int. 2018 Jan;38(1):84-93. doi: 10.1111/liv.13497. Epub 2017 Jul 7.
本文引用的文献
1
Baveno VI Recommendation on Avoidance of Screening Endoscopy in Cirrhotic Patients: Are We There Yet?《巴韦诺 VI 关于避免对肝硬化患者进行筛查性内镜检查的建议：我们做到了吗？》
GE Port J Gastroenterol. 2017 Mar;24(2):79-83. doi: 10.1159/000452693. Epub 2016 Nov 18.
2
Validating the Baveno VI recommendations for screening varices.验证巴韦诺VI关于静脉曲张筛查的建议。
J Hepatol. 2017 Feb;66(2):459-460. doi: 10.1016/j.jhep.2016.09.027. Epub 2016 Nov 5.
3
Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.非侵入性工具与代偿性肝硬化临床显著门静脉高压和静脉曲张风险：“Anticipate”研究。
Hepatology. 2016 Dec;64(6):2173-2184. doi: 10.1002/hep.28824. Epub 2016 Oct 27.
4
Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.验证 Baveno VI 标准以识别低风险肝硬化患者，这些患者无需进行静脉曲张内镜监测。
J Hepatol. 2016 Nov;65(5):899-905. doi: 10.1016/j.jhep.2016.06.021. Epub 2016 Jul 5.
5
Points to be considered when using transient elastography for diagnosis of portal hypertension according to the Baveno's VI consensus.根据巴韦诺VI共识，使用瞬时弹性成像诊断门静脉高压时应考虑的要点。
J Hepatol. 2015 Oct;63(4):1048-9. doi: 10.1016/j.jhep.2015.06.036. Epub 2015 Jul 20.
6
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.门静脉高压领域共识的拓展：巴韦诺VI共识研讨会报告：门静脉高压风险分层与个体化治疗
J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3.
7
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.欧洲肝脏研究学会-阿莱赫临床实践指南：用于评估肝脏疾病严重程度和预后的非侵入性检查
J Hepatol. 2015 Jul;63(1):237-64. doi: 10.1016/j.jhep.2015.04.006. Epub 2015 Apr 21.
8
Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.无症状肝病患者的常规数据和肝硬度检测早期门静脉高压：一项前瞻性研究。
J Hepatol. 2014 Mar;60(3):561-9. doi: 10.1016/j.jhep.2013.10.027. Epub 2013 Nov 6.
9
Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.弹性成像、脾脏大小和血小板计数可用于诊断代偿性肝硬化患者的门静脉高压。
Gastroenterology. 2013 Jan;144(1):102-111.e1. doi: 10.1053/j.gastro.2012.10.001. Epub 2012 Oct 8.
10
Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease.瞬时弹性成像：慢性肝脏疾病中门静脉高压评估的诊断准确性的荟萃分析。
Liver Int. 2013 Jan;33(1):62-71. doi: 10.1111/liv.12003. Epub 2012 Sep 14.
Zotero 插件